Europe

Almirall partners with Proteros

Monday, September 26, 2011 12:31 PM

Spain's Almirall and Proteros of Germany have linked up to develop a treatment in the field of inflammatory diseases, according to PharmaTimes.

More... »

Pfizer to cut 220 jobs in Spain

Thursday, September 22, 2011 11:41 AM

Pfizer has unveiled plans to cut its workforce in Spain by 11%, or 220 staff, driven by the financial crisis in Europe and regulatory moves in the country to reduce its healthcare spend, according to PharmaTimes.

More... »

Merck opens R&D facility in Ireland

Thursday, September 22, 2011 11:27 AM

More good news for the Irish pharmaceutical industry has come with the official opening of Merck's new 100 million euro R&D facility at Ballydine, Co Tipperary, according to PharmaTimes.

More... »

Pfizer to invest $200 million in Irish facility

Tuesday, September 20, 2011 01:33 PM

Pfizer has announced that it is to invest $200 million at its Grange Castle biotechnology manufacturing facility in Clondalkin, Co Dublin, according to PharmaTimes.

More... »

UK firms go to Russia to conduct cheaper clinical trials

Tuesday, September 20, 2011 11:13 AM

Britain's fastest-growing bio-technology firms are flocking to Russia to run clinical trials more cheaply and quickly than they can in the West, according to This is MONEY.

More... »

Re-accredited Russian investigative sites jump to almost 600 under new regulations’ Sept. 1 deadline

Monday, September 19, 2011 08:00 AM

The number of investigative sites that have been re-accredited by the Russian Ministry of Health (MoH)—a requirement inherent in the country’s new regulations—is now up to almost 600, according to the Association of Clinical Trials Organizations (ACTO), a trade group for those working in research in Russia.

More... »

MHRA may allow drug reaction reporting through social media

Tuesday, September 13, 2011 01:23 PM

Drug reaction reporting from smartphones, Facebook and Twitter is being considered after the success of a scheme allowing direct reporting from GP practice IT systems, according to GP Online.

More... »

Report: EMA’s system of comparing drugs is flawed

Friday, September 9, 2011 11:52 AM

The European system of comparing drugs against placebo and not against a comparator is flawed, according to researchers at the London School of Economics, reported InPharm.

More... »

Rhenovia’s RHETOX project receives EUR 1.15 million in financing

Thursday, September 1, 2011 11:06 AM

Rhenovia Pharma has been selected by the French Armaments Directorate (DGA) and the General Directorate for Competitiveness, Industry and Services of the French Ministry of Economy, Finance and Industry (DGCIS) for inclusion in the RAPID program (Support Regime for Dual Innovation in SMEs). By this distinction, Rhenovia will lead a research program, named RHETOX, which will be conducted in partnership with the French Army’s Biomedical Research Institute (IRBA). Rhenovia will receive EUR 850,000 from a global funding amount of EUR 1.15 million.

More... »

The Research Network operates from former Pfizer site

Thursday, September 1, 2011 10:25 AM

A company set up by a group of former Pfizer employees is one of the first businesses to be based at the east Kent site which Pfizer is leaving, according to BBC Mobile.

More... »